- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Report
- September 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- September 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- September 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- September 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- July 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- April 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- April 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- July 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Report
- January 2025
- 180 Pages
Global
From €3989EUR$4,500USD£3,471GBP
- Report
- August 2025
- 146 Pages
Global
From €2659EUR$2,999USD£2,313GBP
- Report
- May 2025
- 150 Pages
Global
From €2659EUR$2,999USD£2,313GBP
- Report
- July 2025
- 208 Pages
Global
From €2216EUR$2,500USD£1,928GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Report
- July 2025
- 350 Pages
Global
From €4387EUR$4,949USD£3,817GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more